Analysis of Erythrocyte Indices and Reticulocyte Hemoglobin Equivalent in Iron Deficiency Anemia on Treatment
DOI:
https://doi.org/10.24293/ijcpml.v29i2.1991Keywords:
Erythrocyte indices, Ret-He, IDA responseAbstract
Assessment of treatment response is needed in the management of iron deficiency anemia (IDA). This study aims to analyze erythrocyte indices (MCH, MCV, MCHC) and Ret-He as indicators of IDA diagnosis and treatment response. A prospective cohort study in children ages 2-18 years old in orphanages throughout Makassar. Grouped into normal group and therapy group, consisting of IDA and iron deficiency groups. Elemental iron therapy 3mg/kg/day was given. Levels of MCV (fl), MCH (pg), MCHC (g/dL), and Ret-He (pg) were measured before and on the 8th day of therapy. The normality test of numerical variable data used the Kolmogorov-Smirnov test. The statistical test used the Mann-Whitney test, Wilcoxon Signed Rank test, and the Kruskal-Wallis test. Diagnostic value and cut-off determination using ROC curve analysis. Test results were significant if p<0.05. The sample consisted of 40 subjects each in both normal and therapy groups. The therapy group was divided into 7 IDA and 33 iron deficiency. ROC IDA curve on MCV obtained a cut-off of 76 fl, a sensitivity of 100%, a specificity of 95%, NPP of 77.8%, NPN of 100%, MCH obtained a cut-off of 25 pg, a sensitivity of 100%, 97.5% specificity of 97.5%, NPP of 87.5%, NPN of 100%, Ret-He obtained cut-off 29 pg, sensitivity of 100%, specificity of 95%, NPP of 77.5%, NPN of 100%. MCV levels increased by 7.3% (p<0.05) while Ret-He increased by 19.6% (p<0.05) after therapy. The ROC curve coordinate on IDA showed that cut-off levels of MCV 76 fl, MCH 25 pg, and Ret-He 29 pg provided optimal sensitivity and specificity. Increasing MCV after therapy described increasing levels in erythrocyte and hematocrit synthesis. Increasing Ret-He after therapy described improving erythropoiesis quality. MCV, MCH, and Ret-He as indicators of diagnosing IDA. MCV and Ret-He monitor the success of IDA treatment response.
Downloads
References
Windiastuti E, Nency YM, Mulatsih S. Anemia defisiensi besi. Buku ajar hematologi-onkologi anak. Ed revisi., Jakarta, Badan Penerbit Ikatan Dokter Anak Indonesia, 2018; 27–39.
Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anemia. Lancet, 2016; 387(10021): 907–16.
Kurniati I. Anemia defisiensi zat besi (Fe) Iron deficiency (Fe) anemia. J Kedokt Univ Lampung, 2020; 4(1): 18–33.
Andriastuti M, Adiwidjaja M, Satari HI. Diagnosis of iron deficiency and iron deficiency anemia with reticulocyte hemoglobin content among children aged 6-18 years. Iran J Blood Cancer, 2019;11(4):127–32.
Auerbach M, Staffa SJ, Brugnara C. Using reticulocyte hemoglobin equivalent as a marker for iron deficiency and responsiveness to iron therapy. Mayo Clin Proc [Internet]. 2021; 96(6):1510–9. Available from: https://doi.org/10.1016/j.mayocp.2020.10.042 (accessed Sept 2, 2021).
Uçar MA, Falay M, Daǧdas S, Ceran F, Urlu SM, Özet G. The importance of RET-He in the diagnosis of iron deficiency and iron deficiency anemia and the evaluation of response to oral iron therapy. J Med Biochem, 2019; 38(4):496–502.
Triwinarni C, Hartini TNS, Susilo J. Hubungan status gizi dengan kejadian Anemia Gizi Besi (AGB) pada siswi SMA di Kecamatan Pakem. J Nutr, 2017;19(1):61–7.
Wahyuni S. Pengaruh suplementasi Fe dan vitamin C terhadap hemoglobin dan indeks eritrosit remaja putri (The effect of iron and vitamin C supplementation on hemoglobin and erythrocyte index in teenager). J Kesehat [Internet]. 2021; 12(2): 162–72. Available from: http://ejurnal.poltekkes-tjk.ac.id/index.php/JK (accessed Sept 2, 2021).
Ratnaningsih T, Mulyono B, Sutaryo S, Dwiprahasto I. Kesahihan Diagnostik hemoglobin retikulosit untuk deteksi defisiensi zat besi di kehamilan. Indones J Clin Pathol Med Lab, 2016; 21(3): 285.
Urrechaga Igartua E, Hoffmann JJML, Izquierdo-ílvarez S, Escanero JF. Reticulocyte hemoglobin content (MCHr) in the detection of iron deficiency. J Trace Elem Med Biol [Internet]. 2017;43:29–32. Available from: http://dx.doi.org/10.1016/j.jtemb.2016.11.001 (accessed Sept 2, 2021).
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
![Creative Commons License](http://i.creativecommons.org/l/by-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.